Lee Ainslie's ABVX Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 40,000 shares of ABIVAX Société Anonyme (ABVX) worth $5.33 M, representing 0.05% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Lee Ainslie has initiated a new position in ABVX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's ABIVAX Société Anonyme (ABVX) Holding Value Over Time
Track share changes against reported price movement
Quarterly ABIVAX Société Anonyme (ABVX) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +40,000 | New Buy | 40,000 | $133.26 |
Lee Ainslie's ABIVAX Société Anonyme Investment FAQs
Lee Ainslie first purchased ABIVAX Société Anonyme (ABVX) in Q2 2026, acquiring 40,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held ABIVAX Société Anonyme (ABVX) for 1 quarters since Q2 2026.
Lee Ainslie's largest addition to ABIVAX Société Anonyme (ABVX) was in Q2 2026, adding 40,000 shares worth $5.33 M.
According to the latest 13F filing for Q2 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 40,000 shares of ABIVAX Société Anonyme (ABVX), valued at approximately $5.33 M.
As of the Q2 2026 filing, ABIVAX Société Anonyme (ABVX) represents approximately 0.05% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in ABIVAX Société Anonyme (ABVX) was 40,000 shares, as reported at the end of Q2 2026.